908 Devices (MASS) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Roth Capital | Maintained | Buy | $13.00 from $11.00 | Aug 12, 2026 |
| Stifel | Maintained | Buy | $12.00 from $10.00 | Aug 12, 2026 |
| Roth Capital | Initiated Coverage | Buy | $11.00 | Jul 29, 2026 |
| Leerink Partners | Upgraded | Market Perform → Outperform | $12.00 | Aug 5, 2025 |
| Stephens & Co. | Maintained | Overweight | $6.00 | Jan 15, 2025 |
| Stifel | Maintained | Buy | $6.00 from $17.00 | Nov 13, 2024 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $4.00 from $12.00 | Nov 13, 2024 |
| Leerink Partners | Maintained | Outperform | $12.00 from $15.00 | Oct 17, 2024 |
| Stephens & Co. | Maintained | Overweight | $14.00 | May 13, 2024 |
| Stephens & Co. | Maintained | Overweight | $14.00 | Sep 25, 2023 |
Frequently asked questions
Is MASS a buy, sell, or hold?
Analysts covering 908 Devices currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MASS?
On Aug 12, 2026, Roth Capital maintained 908 Devices at Buy with a price target of $13.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.